Test Price
2,800 AED✅ Home Collection Available
AHDC1 Gene Genetic Test (Intellectual Disability, Autosomal Dominant Type 25 / MRD25) in UAE | 2800 AED | DHA Licensed
Executive Summary & Core Metrics
- Accuracy Guarantee: 99.9% Diagnostic Sensitivity via ISO 9001:2015 Certified NGS Workflow.
- Premium Logistics: VIP Mobile Phlebotomy & Temperature-Controlled Cold-Chain Home Collection (Available daily from 8 AM to 11 PM).
- Clinical Guidance: Complimentary Telephonic Post-Test Clinical Guidance by a DHA-licensed Consultant Medical Geneticist.
- Insurance: Direct Billing Verification via WhatsApp +971 54 548 8731.
Test Overview & Methodology
This NGS‑based test sequences the entire coding region of the AHDC1 gene to detect pathogenic variants responsible for autosomal dominant intellectual disability (MRD25). It is a definitive tool for confirming clinical diagnoses in patients with neurodevelopmental delay, congenital anomalies, and for guiding reproductive decision‑making.
| Feature | Our Test (AHDC1 NGS) | Closest Alternative (Panel / Exome) |
|---|---|---|
| Precision | Single‑gene full coverage; detection of SNVs, indels, CNVs | Multi‑gene panels may miss deep intronic variants; higher incidental findings |
| Methodology | Next‑Generation Sequencing (NGS) with Sanger validation | NGS panel or Whole Exome Sequencing (less focused) |
| Turnaround Time | 3–4 Weeks | 8–12 Weeks (Exome) |
Physician Insight & Safety Protocols
Insight from Genetics Consultant
“As a medical geneticist, I understand that pursuing genetic testing for intellectual disability can be emotionally challenging. This test provides essential molecular answers, but results must be interpreted alongside the full clinical picture by a qualified specialist. A negative result does not exclude all genetic aetiologies; genetic counselling remains a cornerstone of your journey.”
— Lina Osama Zaki Quteineh, Consultant Medical Genetics, DHA Registration ID: 9294403
Medication Advisory
Do not discontinue any prescribed medication without consulting your treating physician. Genetic test results may influence therapy but never replace clinical judgement.
Exclusion Criteria & Safety Red Flags
- Not indicated for asymptomatic minors without parental consent, in compliance with Federal Law No. 2 of 2019 concerning health information and consent.
- Prenatal testing requires prior invasive sampling (amniocentesis/CVS) – not performed on maternal blood alone.
- Seek Emergency Care if: sudden seizure onset, rapid neurological regression, loss of previously acquired skills, or severe behavioural changes.
Patient FAQ & Clinical Guidance
1. What is the turnaround time for the AHDC1 gene test?
Results are typically delivered 3 to 4 weeks after sample arrival, due to extensive NGS analysis and confirmatory Sanger sequencing.
2. Is a blood sample the only requirement, and do I need any special preparation?
A standard venous blood draw is sufficient; no fasting is required, but a pre‑test genetic counselling session is mandatory to document family history.
3. Can this test be used for prenatal diagnosis or carrier screening?
Yes, after appropriate genetic counselling, it can be applied to prenatal specimens (amniotic fluid or CVS) and for cascade carrier testing in at‑risk relatives.
UAE Regulatory & Data Privacy Adherence
Data Protection & Compliance
Genetic testing is performed in full accordance with Federal Decree‑Law No. 45 of 2021 on Personal Data Protection (PDPL) and Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields. Clinical safety and patient consent follow Federal Decree‑Law No. 4 of 2016 on Medical Liability. Facility licensed under DHA License 1143, premises at Dubai Healthcare City.
Clinical & Logistical Metadata
| Test Name | AHDC1 Gene Genetic Test (Intellectual Disability, Autosomal Dominant Type 25 / MRD25) |
| Price (AED) | 2,800 |
| Turnaround Time | 3–4 Weeks |
| Sample Type / Matrix | Peripheral whole blood (venous) |
| Methodology Used | Next‑Generation Sequencing (NGS) with Sanger validation |
| ICD-10-CM Code | F70 (Mild intellectual disabilities), Q87.8 (Other cong. malformation syndromes) |
| LOINC Code | 96605-2 (AHDC1 gene full sequencing) |
| DHA Facility License & Address | License: 1143 | Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE |
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians